№ lp_1_2_15034
File format: docx Character count: 26910 File size: 116 KB
This document outlines the procedures and criteria for managing hyperemesis gravidarum in pregnant women through the Hospital in the Home (HITH) service, detailing referral processes, admission criteria, medical treatment, and patient assessment protocols.
Year: 2023
Region / City: Canberra
Topic: Hyperemesis Gravidarum, Pregnancy Care
Document Type: Procedure
Organization: Canberra Health Services
Author: Not specified
Target Audience: Clinical staff at CHS, external referrers, medical and nursing professionals
Period of Application: Ongoing
Approval Date: Not specified
Amendment Date: Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Supplementary Materials for Muscular Tissue Oxygen Saturation and Posthysterectomy Nausea and Vomiting: The iMODIPONV Randomized Controlled Trial
Document type: Supplementary materials
Study type: Randomized controlled trial
Trial name: iMODIPONV
Medical field: Anesthesiology
Clinical focus: Postoperative nausea and vomiting after hysterectomy
Primary variable: Muscular tissue oxygen saturation
Population: Posthysterectomy patients
Study design: Multicenter
Participating institutions: University and provincial hospitals
Countries involved: China, United States
Committees: Steering Committee, Quality Committee, Data Safety Monitoring Board
Data included: Site investigators, coordinators, hospital participation, treatment assignment, randomization errors
Analyses: Sensitivity analyses, multivariable logistic regression
Supplementary content: Figures and tables
Source type: Supplement to a peer-reviewed clinical trial publication
Guidance on the Suggested Use of Medical Cannabis for Cancer and Chemotherapy-Induced Nausea and Vomiting
Year: 2023
Region / city: Utah
Topic: Medical Cannabis, Cancer Treatment
Document type: Guidance
Institution: Utah Cannabis Research Review Board, Department of Health and Human Services
Author: Utah Cannabis Research Review Board, Department of Health and Human Services staff
Target audience: Medical providers, patients, caregivers
Period of validity: Ongoing
Approval date: Not specified
Date of changes: Not specified
Topics: Hyperemesis Gravidarum Nausea